Theoretical Benefits of Dynamic Collimation in Pencil Beam Scanning Proton Therapy for Brain Tumors: Dosimetric and Radiobiological Metrics

Alexandra Moignier, Edgar Gelover, Dongxu Wang, Blake Smith, Ryan Flynn, Maura Kirk, Liyong Lin, Timothy Solberg, Alexander Lin, Daniel Hyer

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Purpose To quantify the dosimetric benefit of using a dynamic collimation system (DCS) for penumbra reduction during the treatment of brain tumors by pencil beam scanning proton therapy (PBS PT). Methods and Materials Collimated and uncollimated brain treatment plans were created for 5 patients previously treated with PBS PT and retrospectively enrolled in an institutional review board-approved study. The in-house treatment planning system, RDX, was used to generate the plans because it is capable of modeling both collimated and uncollimated beamlets. The clinically delivered plans were reproduced with uncollimated plans in terms of target coverage and organ at risk (OAR) sparing to ensure a clinically relevant starting point, and collimated plans were generated to improve the OAR sparing while maintaining target coverage. Physical and biological comparison metrics, such as dose distribution conformity, mean and maximum doses, normal tissue complication probability, and risk of secondary brain cancer, were used to evaluate the plans. Results The DCS systematically improved the dose distribution conformity while preserving the target coverage. The average reduction of the mean dose to the 10-mm ring surrounding the target and the healthy brain were 13.7% (95% confidence interval [CI] 11.6%-15.7%; P

Original languageEnglish (US)
Pages (from-to)171-180
Number of pages10
JournalInternational Journal of Radiation Oncology Biology Physics
Volume95
Issue number1
DOIs
StatePublished - May 1 2016

Fingerprint

Proton Therapy
pencil beams
collimation
Brain Neoplasms
Organs at Risk
brain
therapy
tumors
scanning
protons
dosage
Research Ethics Committees
Brain
organs
Therapeutics
Confidence Intervals
penumbras
RDX
preserving
planning

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Radiation
  • Cancer Research

Cite this

Theoretical Benefits of Dynamic Collimation in Pencil Beam Scanning Proton Therapy for Brain Tumors : Dosimetric and Radiobiological Metrics. / Moignier, Alexandra; Gelover, Edgar; Wang, Dongxu; Smith, Blake; Flynn, Ryan; Kirk, Maura; Lin, Liyong; Solberg, Timothy; Lin, Alexander; Hyer, Daniel.

In: International Journal of Radiation Oncology Biology Physics, Vol. 95, No. 1, 01.05.2016, p. 171-180.

Research output: Contribution to journalArticle

Moignier, Alexandra ; Gelover, Edgar ; Wang, Dongxu ; Smith, Blake ; Flynn, Ryan ; Kirk, Maura ; Lin, Liyong ; Solberg, Timothy ; Lin, Alexander ; Hyer, Daniel. / Theoretical Benefits of Dynamic Collimation in Pencil Beam Scanning Proton Therapy for Brain Tumors : Dosimetric and Radiobiological Metrics. In: International Journal of Radiation Oncology Biology Physics. 2016 ; Vol. 95, No. 1. pp. 171-180.
@article{c1439dcf9eb14a29993f63d0d5c85d15,
title = "Theoretical Benefits of Dynamic Collimation in Pencil Beam Scanning Proton Therapy for Brain Tumors: Dosimetric and Radiobiological Metrics",
abstract = "Purpose To quantify the dosimetric benefit of using a dynamic collimation system (DCS) for penumbra reduction during the treatment of brain tumors by pencil beam scanning proton therapy (PBS PT). Methods and Materials Collimated and uncollimated brain treatment plans were created for 5 patients previously treated with PBS PT and retrospectively enrolled in an institutional review board-approved study. The in-house treatment planning system, RDX, was used to generate the plans because it is capable of modeling both collimated and uncollimated beamlets. The clinically delivered plans were reproduced with uncollimated plans in terms of target coverage and organ at risk (OAR) sparing to ensure a clinically relevant starting point, and collimated plans were generated to improve the OAR sparing while maintaining target coverage. Physical and biological comparison metrics, such as dose distribution conformity, mean and maximum doses, normal tissue complication probability, and risk of secondary brain cancer, were used to evaluate the plans. Results The DCS systematically improved the dose distribution conformity while preserving the target coverage. The average reduction of the mean dose to the 10-mm ring surrounding the target and the healthy brain were 13.7{\%} (95{\%} confidence interval [CI] 11.6{\%}-15.7{\%}; P",
author = "Alexandra Moignier and Edgar Gelover and Dongxu Wang and Blake Smith and Ryan Flynn and Maura Kirk and Liyong Lin and Timothy Solberg and Alexander Lin and Daniel Hyer",
year = "2016",
month = "5",
day = "1",
doi = "10.1016/j.ijrobp.2015.08.030",
language = "English (US)",
volume = "95",
pages = "171--180",
journal = "International Journal of Radiation Oncology Biology Physics",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Theoretical Benefits of Dynamic Collimation in Pencil Beam Scanning Proton Therapy for Brain Tumors

T2 - Dosimetric and Radiobiological Metrics

AU - Moignier, Alexandra

AU - Gelover, Edgar

AU - Wang, Dongxu

AU - Smith, Blake

AU - Flynn, Ryan

AU - Kirk, Maura

AU - Lin, Liyong

AU - Solberg, Timothy

AU - Lin, Alexander

AU - Hyer, Daniel

PY - 2016/5/1

Y1 - 2016/5/1

N2 - Purpose To quantify the dosimetric benefit of using a dynamic collimation system (DCS) for penumbra reduction during the treatment of brain tumors by pencil beam scanning proton therapy (PBS PT). Methods and Materials Collimated and uncollimated brain treatment plans were created for 5 patients previously treated with PBS PT and retrospectively enrolled in an institutional review board-approved study. The in-house treatment planning system, RDX, was used to generate the plans because it is capable of modeling both collimated and uncollimated beamlets. The clinically delivered plans were reproduced with uncollimated plans in terms of target coverage and organ at risk (OAR) sparing to ensure a clinically relevant starting point, and collimated plans were generated to improve the OAR sparing while maintaining target coverage. Physical and biological comparison metrics, such as dose distribution conformity, mean and maximum doses, normal tissue complication probability, and risk of secondary brain cancer, were used to evaluate the plans. Results The DCS systematically improved the dose distribution conformity while preserving the target coverage. The average reduction of the mean dose to the 10-mm ring surrounding the target and the healthy brain were 13.7% (95% confidence interval [CI] 11.6%-15.7%; P

AB - Purpose To quantify the dosimetric benefit of using a dynamic collimation system (DCS) for penumbra reduction during the treatment of brain tumors by pencil beam scanning proton therapy (PBS PT). Methods and Materials Collimated and uncollimated brain treatment plans were created for 5 patients previously treated with PBS PT and retrospectively enrolled in an institutional review board-approved study. The in-house treatment planning system, RDX, was used to generate the plans because it is capable of modeling both collimated and uncollimated beamlets. The clinically delivered plans were reproduced with uncollimated plans in terms of target coverage and organ at risk (OAR) sparing to ensure a clinically relevant starting point, and collimated plans were generated to improve the OAR sparing while maintaining target coverage. Physical and biological comparison metrics, such as dose distribution conformity, mean and maximum doses, normal tissue complication probability, and risk of secondary brain cancer, were used to evaluate the plans. Results The DCS systematically improved the dose distribution conformity while preserving the target coverage. The average reduction of the mean dose to the 10-mm ring surrounding the target and the healthy brain were 13.7% (95% confidence interval [CI] 11.6%-15.7%; P

UR - http://www.scopus.com/inward/record.url?scp=84963500366&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84963500366&partnerID=8YFLogxK

U2 - 10.1016/j.ijrobp.2015.08.030

DO - 10.1016/j.ijrobp.2015.08.030

M3 - Article

C2 - 26614424

AN - SCOPUS:84963500366

VL - 95

SP - 171

EP - 180

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

SN - 0360-3016

IS - 1

ER -